Skip to main navigation
Skip to search
Skip to main content
University of Arizona Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy
Xiaoming Chen
, Mark O. Moore
, Constance D. Lehman
, David A. Mankoff
, Thomas J. Lawton
, Sue Peacock
, Erin K. Schubert
, Robert B. Livingston
Cancer Center
Research output
:
Contribution to journal
›
Article
›
peer-review
66
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Residual Disease
100%
Locally Advanced Breast Cancer
100%
Neoadjuvant Chemotherapy
100%
Clinical Breast Examination
44%
Pathological Complete Response
22%
Pathologic
22%
Complete Response
22%
Response Monitoring
11%
Response Predictors
11%
Pathological Examination
11%
Pathological Response
11%
Standardized Uptake Value
11%
Non-response
11%
Pathological Tumor Response
11%
Clinical Response
11%
Tumor Residual
11%
Response Classification
11%
Disease Assessment
11%
Medicine and Dentistry
Minimal Residual Disease
100%
Neoadjuvant Chemotherapy
100%
Locally Advanced Breast Cancer
100%
Breast Examination
50%
Positron Emission Tomography - Magnetic Resonance Imaging
12%
Patient Care
12%
Standardized Uptake Value
12%
Disease Assessment
12%